ALB and diabetic kidney disease: This study demonstrates that dendritic cell (DC) immunotherapy significantly reduces urinary albumin-to-creatinine ratio (UACR) in diabetic kidney disease (DKD) patients, suggesting its potential as an effective therapeutic approach.